{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:31:50Z","timestamp":1790706710981,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1999,4]]},"DOI":"10.1212\/wnl.52.7.1330","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:39:31Z","timestamp":1336916371000},"page":"1330-1330","source":"Crossref","is-referenced-by-count":251,"title":["A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures"],"prefix":"10.1212","volume":"52","author":[{"given":"V.","family":"Biton","sequence":"first","affiliation":[{"name":"From the Arkansas Epilepsy Program (Dr. Biton)Little Rock, AR; Epi-Care Center (Dr. Montouris), Memphis, TN; The Minnesota Epilepsy Group (Dr. Ritter), St. Paul, MN; Children\u2019s Hospital (Dr. Riviello), Boston, MA; The Corporate Office Science and Technology, Johnson & Johnson (Dr. Reife), New Brunswick, NJ; and the R.W. Johnson Pharmaceutical Research Institute (Drs. Lim and Pledger), Raritan, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.D.","family":"Montouris","sequence":"additional","affiliation":[{"name":"From the Arkansas Epilepsy Program (Dr. Biton)Little Rock, AR; Epi-Care Center (Dr. Montouris), Memphis, TN; The Minnesota Epilepsy Group (Dr. Ritter), St. Paul, MN; Children\u2019s Hospital (Dr. Riviello), Boston, MA; The Corporate Office Science and Technology, Johnson & Johnson (Dr. Reife), New Brunswick, NJ; and the R.W. Johnson Pharmaceutical Research Institute (Drs. Lim and Pledger), Raritan, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ritter","sequence":"additional","affiliation":[{"name":"From the Arkansas Epilepsy Program (Dr. Biton)Little Rock, AR; Epi-Care Center (Dr. Montouris), Memphis, TN; The Minnesota Epilepsy Group (Dr. Ritter), St. Paul, MN; Children\u2019s Hospital (Dr. Riviello), Boston, MA; The Corporate Office Science and Technology, Johnson & Johnson (Dr. Reife), New Brunswick, NJ; and the R.W. Johnson Pharmaceutical Research Institute (Drs. Lim and Pledger), Raritan, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Riviello","sequence":"additional","affiliation":[{"name":"From the Arkansas Epilepsy Program (Dr. Biton)Little Rock, AR; Epi-Care Center (Dr. Montouris), Memphis, TN; The Minnesota Epilepsy Group (Dr. Ritter), St. Paul, MN; Children\u2019s Hospital (Dr. Riviello), Boston, MA; The Corporate Office Science and Technology, Johnson & Johnson (Dr. Reife), New Brunswick, NJ; and the R.W. Johnson Pharmaceutical Research Institute (Drs. Lim and Pledger), Raritan, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Reife","sequence":"additional","affiliation":[{"name":"From the Arkansas Epilepsy Program (Dr. Biton)Little Rock, AR; Epi-Care Center (Dr. Montouris), Memphis, TN; The Minnesota Epilepsy Group (Dr. Ritter), St. Paul, MN; Children\u2019s Hospital (Dr. Riviello), Boston, MA; The Corporate Office Science and Technology, Johnson & Johnson (Dr. Reife), New Brunswick, NJ; and the R.W. Johnson Pharmaceutical Research Institute (Drs. Lim and Pledger), Raritan, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lim","sequence":"additional","affiliation":[{"name":"From the Arkansas Epilepsy Program (Dr. Biton)Little Rock, AR; Epi-Care Center (Dr. Montouris), Memphis, TN; The Minnesota Epilepsy Group (Dr. Ritter), St. Paul, MN; Children\u2019s Hospital (Dr. Riviello), Boston, MA; The Corporate Office Science and Technology, Johnson & Johnson (Dr. Reife), New Brunswick, NJ; and the R.W. Johnson Pharmaceutical Research Institute (Drs. Lim and Pledger), Raritan, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pledger","sequence":"additional","affiliation":[{"name":"From the Arkansas Epilepsy Program (Dr. Biton)Little Rock, AR; Epi-Care Center (Dr. Montouris), Memphis, TN; The Minnesota Epilepsy Group (Dr. Ritter), St. Paul, MN; Children\u2019s Hospital (Dr. Riviello), Boston, MA; The Corporate Office Science and Technology, Johnson & Johnson (Dr. Reife), New Brunswick, NJ; and the R.W. Johnson Pharmaceutical Research Institute (Drs. Lim and Pledger), Raritan, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Topiramate YTC Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb02459.x"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(97)00045-4"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1996.tb00649.x"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.6.1684"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.6.1678"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(96)00029-0"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1996.tb00606.x"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91603-8"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(96)00020-4"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1981.tb06159.x"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1985.tb05417.x"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"e_1_3_1_14_2","unstructured":"SAS\/STAT Users\u2019 Guide. Version 6 4th ed. Cary NC: SAS Institute May 1992."},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00031305.1981.10479327","volume":"35","year":"1981","unstructured":"Conover WJ, Iman RL. Rank transformations as a bridge between parametric and nonparametric statistics. Am Statistician 1981;35:124\u2013133.","journal-title":"Am Statistician"},{"key":"e_1_3_1_16_2","unstructured":"Fleiss  JL.  Statistical Methods for Rates and Proportions. 2nd ed. New York:John Wiley and Sons 1981:173\u2013175."},{"key":"e_1_3_1_17_2","unstructured":"Lehmann  EL.  Nonparametrics: Statistical Methods Based on Ranks. San Francisco:Holden Day 1975:5\u201342."},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.52.7.1330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:27:40Z","timestamp":1711553260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.52.7.1330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1999,4]]}},"alternative-id":["10.1212\/WNL.52.7.1330"],"URL":"https:\/\/doi.org\/10.1212\/wnl.52.7.1330","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4]]}}}